1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla]
RxNorm concept 2644523, branded drug (sbd). Prescribable name: Ngenla 24 MG in 1.2 ML Pen Injector.
- RxCUI
- 2644523
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2644523 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Ngenla 20 MG/ML per 1.2 ML Pen Injector; Ngenla 24 MG per 1.2 ML Pen Injector
Related concepts
- somatrogon-ghla 20 MG/ML (SCDC, consists of)
- somatrogon-ghla 20 MG/ML [Ngenla] (SBDC, consists of)
- Pen Injector (DF, has dose form)
- Ngenla (BN, has ingredient)
- 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2644523 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2644523 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2644523. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.